Compare · CUVL vs DXST

CUVL vs DXST

Side-by-side comparison of Clinuvel Pharmaceuticals Limited (CUVL) and Decent Holding Inc (DXST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CUVL and DXST operate in Miscellaneous (Industrials), so they compete in similar markets.
  • CUVL is the larger of the two at $247.1M, about 163.8x DXST ($1.5M).
  • DXST has hit the wire 4 times in the past 4 weeks while CUVL has been quiet.
MetricCUVLDXST
Company
Clinuvel Pharmaceuticals Limited
Decent Holding Inc
Price
-
-
Market cap
$247.1M
$1.5M
1M return
-
-45.95%
1Y return
-
-98.36%
Industry
Miscellaneous
Miscellaneous
Exchange
NASDAQ
NASDAQ
IPO
2025
News (4w)
0
4
Recent ratings
0
0
CUVL

Clinuvel Pharmaceuticals Limited

CLINUVEL is a global biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic, and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. CLINUVEL is listed on the Australian Securities Exchange (ASX: CUV) and the Nasdaq Stock Market (Nasdaq: CUVL).